Removal of cellular-type hemoglobin-based oxygen carrier (hemoglobin-vesicles) from blood using centrifugation and ultrafiltration.

about

Artificial Organs 2012: a year in review.

P2860

Q38086289-24727D96-DEF1-41EC-B83D-5B8AA5CDEEB0

P2860

Removal of cellular-type hemoglobin-based oxygen carrier (hemoglobin-vesicles) from blood using centrifugation and ultrafiltration.

Item

http://www.wikidata.org/entity/Q50528068

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Removal of cellular-type hemog ...... ifugation and ultrafiltration.

@en

Removal of cellular-type hemoglobin-based oxygen carrier

@nl

type

Item

label

Removal of cellular-type hemog ...... ifugation and ultrafiltration.

@en

Removal of cellular-type hemoglobin-based oxygen carrier

@nl

prefLabel

Removal of cellular-type hemog ...... ifugation and ultrafiltration.

@en

Removal of cellular-type hemoglobin-based oxygen carrier

@nl

P1476

Removal of cellular-type hemog ...... ifugation and ultrafiltration.

@en

P2093

Eishun Tsuchida

http://www.w3.org/2001/XMLSchema#string

Hirohisa Horinouchi

http://www.w3.org/2001/XMLSchema#string

Koichi Kobayashi

http://www.w3.org/2001/XMLSchema#string

P2860

The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation.

Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.

Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.

Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment.

Characteristics of bovine hemoglobin as a potential source of hemoglobin-vesicles for an artificial oxygen carrier.

Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days.

Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier.

Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.

Effect of hemoglobin vesicle, a cellular-type artificial oxygen carrier, on middle cerebral artery occlusion- and arachidonic acid-induced stroke models in rats.

Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.

P304

202-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1525-1594.2011.01236.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Keitaro Sou

Hiromi Sakai

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21834949

http://www.w3.org/2001/XMLSchema#string

Removal of cellular-type hemoglobin-based oxygen carrier (hemoglobin-vesicles) from blood using centrifugation and ultrafiltration.

about

P2860

P2860

Removal of cellular-type hemoglobin-based oxygen carrier (hemoglobin-vesicles) from blood using centrifugation and ultrafiltration.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698